The DOI matches its Crossref record; 471 of the 471 references it cites were found in a registry or an index.
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Open accessAbstract
national Society for Heart and Lung Transplantation; d Representing the European League Against Rheumatism; and e Representing the European Society of Radiology.ESC entities having participated in the development of this document: ESC Associations: Acute Cardiovascular Care Association (ACCA), European Association for Cardiovascular Prevention & Rehabilitation (EACPR), European Association of Cardiovascular Imaging (EACVI), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA).ESC Councils: Council for Cardiology Practice (CCP), Council on Cardiovascular Nursing and Allied Professions (CCNAP), Council on Cardiovascular Primary Care (CCPC).ESC Working Groups: Cardiovascular Pharmacotherapy, Cardiovascular Surgery, Grown-up Congenital Heart Disease, Pulmonary Circulation and Right Ventricular Function, Valvular Heart Disease.The content of these European Society of Cardiology (ESC) and European Respiratory Society (ERS) Guidelines has been published for personal and educational use only.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ESC/ERS model also employs the assessment of risk using a multi-parametric comprehensive analysis of clinical variables.(284) Unlike REVEAL, this model avoids use of any non-modifiable criteria, and does not “weight” the variables according to their relative importance.”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [284]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Unlike REVEAL, this model avoids use of any non-modifiable criteria, and does not “weight” the variables according to their relative importance.”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [284]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“transplantation may be necessary if prostacyclin treatment is required for an appropriate intervention, there is accompanying liver or renal failure, or severe hemoptysis is present [3,59-62]”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The two most frequently used risk assessment models are the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management (REVEAL) 2.0 and the 2015 European Society of Cardiology/European Respiratory Society (ESC/ERS) model.(283, 284)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [284]
The cited source says what the claim attributes to it.
In the citing paper
“The ESC/ERS model also employs the assessment of risk using a multi-parametric comprehensive analysis of clinical variables.(284)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [284]
The cited source says what the claim attributes to it.
In the citing paper
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–471 of 471
Rosenzweig, E. B., Brodie, D., Abrams, D. C., Agerstrand, C. L., & Bacchetta, M. D. (2013) · ASAIO Journal · doi:10.1097/mat.0000000000000021 · Cited by 85
Imaging in Pulmonary Hypertension
Lang, I. M., Plank, C. M., Sadushi‐Kolici, R., et al. (2010) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.09.013 · Cited by 84
Self-citationComplications Leading to Sudden Cardiac Death in Pulmonary Arterial Hypertension
Demerouti, E., Manginas, A. N., Athanassopoulos, G. D., et al. (2013) · Respiratory Care · doi:10.4187/respcare.02252 · Cited by 84
Fibrinogen, T-PA, and PAI-1 Plasma Levels in Patients with Pulmonary Hypertension
Huber, K., Beckmann, R. A., Frank, H., et al. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921465 · Cited by 81
Kawut, S. M., Horn, E. M., Berekashvili, K. K., et al. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2355 · Cited by 80
Avouac, J., Wipff, J., Kahan, A., & Allanore, Y. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.077149 · Cited by 79
Self-citationIron deficiency in systemic sclerosis patients with and without pulmonary hypertension
Ruiter, G., Lanser, I., de Man, F. S., van der Laarse, W. J., Wharton, J., Wilkins, M. R., Howard, L., Noordegraaf, A. V., & Voskuyl, A. E. (2013) · Rheumatology · doi:10.1093/rheumatology/ket331 · Cited by 78
Choong, C. K. C., Sweet, S. C., Guthrie, T. J., Mendeloff, E. N., Haddad, F. J., Schuler, P., de la Morena, M., & Huddleston, C. B. (2005) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.07.058 · Cited by 77
Pulmonary arterial hypertension in patients treated with interferon
Savale, L., Chaumais, M., Sitbon, O., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01376-2015 · Cited by 77
Challenges in the diagnosis and treatment of pulmonary arterial hypertension
Vachiéry, J., & Gaine, S. (2012) · European Respiratory Review · doi:10.1183/09059180.00005412 · Cited by 75
Self-citationNoninvasive cardiac output measurements in patients with pulmonary hypertension
Rich, J. D., Archer, S. L., & Rich, S. (2012) · European Respiratory Journal · doi:10.1183/09031936.00102212 · Cited by 74
Vachiéry, J., Huez, S., Gillies, H., Layton, G. R., Hayashi, N., Gao, X., & Naeije, R. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03831.x · Cited by 73
Bárbaro, G., Lucchini, A., Pellicelli, A. M., et al. (2006) · Heart · doi:10.1136/hrt.2005.076794 · Cited by 73
Combination Therapy in Pulmonary Arterial Hypertension: A Meta-Analysis
Bai, Y., Sun, L., Hu, S., & Wei, Y. (2011) · Cardiology · doi:10.1159/000334431 · Cited by 71
Kia, L., Shah, S. J., Wang, E., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12385 · Cited by 70
Ventilation/perfusion lung scan in pulmonary veno-occlusive disease
Seferian, A., Helal, B., Jaïs, X., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00097911 · Cited by 70
Rubin, L. J., Hoeper, M. M., Klepetko, W., Galiè, N., Lang, I. M., & Simonneau, G. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-111lr · Cited by 68
Self-citationLee, M. S., Oyama, J. K., Bhatia, R., et al. (2010) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22592 · Cited by 67
van Albada, M. E., & Berger, R. M. F. (2008) · Cardiology in the Young · doi:10.1017/s1047951107001849 · Cited by 66
Sitbon, O., Delcroix, M., Bergot, E., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.08.007 · Cited by 65
Sun, P.-Y., Jiang, X., Gomberg‐Maitland, M., Zhao, Q., He, J., Yuan, P., Zhang, R., & Jing, Z. (2011) · CHEST Journal · doi:10.1378/chest.10-3331 · Cited by 65
Sakai, T., Planinsic, R. M., Mathier, M. A., et al. (2009) · Transplant International · doi:10.1111/j.1432-2277.2008.00830.x · Cited by 62
Launay, D., Savale, L., BEREZNE, A., Pavec, J. L., HACHULLA, E., Mouthon, L., Sitbon, O., Lambert, B., Gaudric, M., Jaïs, X., et al. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.01.020 · Cited by 61
Self-citationFrost, A., Farber, H. W., Barst, R. J., et al. (2012) · CHEST Journal · doi:10.1378/chest.11-1387 · Cited by 61
Dardi, F., Manes, A., Palazzini, M., Bachetti, C., Mazzanti, G., Rinaldi, A., Albini, A., Gotti, E., Monti, E., Reggiani, M. L. B., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00209914 · Cited by 60
Self-citationGhofrani, H. A., Distler, O., Gerhardt, F., et al. (2011) · International Journal of Cardiology · doi:10.1016/s0167-5273(11)70490-9 · Cited by 59
Imaging Findings in Pulmonary Vasculitis
Castañer, E., Alguersuari, A., Andreu, M., et al. (2012) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2012.05.001 · Cited by 59
Boudjemline, Y., Patel, M. B., Malekzadeh-Milani, S. G., et al. (2013) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.000091 · Cited by 58
Chronic thromboembolic pulmonary hypertension in pediatric patients
Madani, M. M., Wittine, L. M., Auger, W. R., Fedullo, P. F., Kerr, K. M., Kim, N. H., Test, V. J., Kriett, J. M., & Jamieson, S. W. (2010) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2010.07.010 · Cited by 55
Raevens, S., Pauw, M. D., Reyntjens, K. M. E. M., et al. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835c504b · Cited by 55
Nawaz, A., Litt, H. I., Stavropoulos, S. W., et al. (2008) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2008.07.011 · Cited by 52
Sugiyama, M., Fukuda, T., Sanda, Y., et al. (2014) · Japanese Journal of Radiology · doi:10.1007/s11604-014-0319-8 · Cited by 51
The trajectory to diagnosis with pulmonary arterial hypertension: a qualitative study
Armstrong, I., Rochnia, N., Harries, C., Bundock, S., & Yorke, J. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000806 · Cited by 51
Althoff, T. F., Knebel, F., Panda, A., et al. (2008) · CHEST Journal · doi:10.1378/chest.07-1222 · Cited by 50
Showkathali, R., Tayebjee, M. H., Grapsa, J., Alzetani, M., Nihoyannopoulos, P., Howard, L., Lefroy, D. C., & Gibbs, J. S. R. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.02.059 · Cited by 49
Self-citationRapp, A. H., Lange, R. A., Cigarroa, J. E., Keeley, E. C., & Hillis, L. D. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01864-1 · Cited by 48
McLaughlin, V. V., Channick, R. W., Chin, K., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(15)61538-8 · Cited by 46
Swift, A. J., Rajaram, S., Marshall, H., et al. (2011) · European Radiology · doi:10.1007/s00330-011-2306-0 · Cited by 45
Adatia, I., Haworth, S. G., Wegner, M., et al. (2013) · Pulmonary Circulation · doi:10.4103/2045-8932.109931 · Cited by 44
Extracorporeal Membrane Oxygenation as a Bridge to Pulmonary Endarterectomy
Mydin, M., Berman, M., Klein, A. A., et al. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.05.035 · Cited by 44
Ambrisentan Improves Exercise Capacity and Symptoms in Patients with Portopulmonary Hypertension
Halank, M., Knudsen, L., Seyfarth, H.-J., et al. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0031-1273393 · Cited by 43
New Treatment Strategies for Pulmonary Arterial Hypertension
Galiè, N., & Manes, A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.032 · Cited by 42
Self-citationRaines, D. E., Liberthson, R. R., & Murray, J. R. (1996) · Journal of Clinical Anesthesia · doi:10.1016/0952-8180(96)00084-0 · Cited by 42
Douwes, J. M., Roofthooft, M. T. R., van Loon, R. L. E., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-304895 · Cited by 41
Standards of Care in Pulmonary Hypertension
Barberà, J. A., Escribano, P., Morales, P., et al. (2008) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60093-6 · Cited by 39
Self-citationCharacterization of Pulmonary Hypertension in Heart Failure Using the Diastolic Pressure Gradient
Chatterjee, N. A., & Lewis, G. D. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.09.002 · Cited by 39
Cesarean section under epidural ropivacaine 0.75% in a parturient with severe pulmonary hypertension
Olofsson, C., Bremme, K. A., Forssell, G., & Öhqvist, G. (2001) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2001.450220.x · Cited by 37
Pre-implantation genetic diagnosis in pulmonary arterial hypertension due toBMPR2mutation: Figure 1–
Frydman, N., Steffann, J., Girerd, B., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00185011 · Cited by 37
Long-Term Effects of Cicletanine on Secondary Pulmonary Hypertension
Saadjian, A., Philip‐Joet, F., Paganelli, F. F., et al. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199803000-00006 · Cited by 36
Pulmonary hypertension due to chronic hypoxia.
Peacock, A. (1990) · BMJ · doi:10.1136/bmj.300.6727.763 · Cited by 34
Self-citationŻyłkowska, J., Kurzyna, M., Pietura, R., et al. (2011) · CHEST Journal · doi:10.1378/chest.10-1134 · Cited by 34
Self-citationEstándares asistenciales en hipertensión pulmonar
Barberà, J. A., Escribano, P., Morales, P., et al. (2008) · Revista Española de Cardiología · doi:10.1157/13116205 · Cited by 33
Self-citationSchulze‐Neick, I., & Beghetti, M. (2008) · Cardiology in the Young · doi:10.1017/s1047951107001850 · Cited by 33
Self-citationUpdate in systemic sclerosis-associated pulmonary arterial hypertension
Gashouta, M. A., Humbert, M. J. C., & Hassoun, P. M. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.06.007 · Cited by 33
Self-citationO’Callaghan, D. S., Dorfmüller, P., Jaïs, X., et al. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2010.10.017 · Cited by 33
Measurement, interpretation and use of hemodynamic parameters
Lopes, A. A., & O’Leary, P. W. (2009) · Cardiology in the Young · doi:10.1017/s1047951109003886 · Cited by 33
Hager, W. D., Collins, I., Tate, J. P., et al. (2012) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2012.00310.x · Cited by 33
Pulmonary Hypertension Associated with Left-Sided Heart Disease
Barnett, C. F., & Marco, T. D. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.04.009 · Cited by 32
Registries for paediatric pulmonary hypertension
Hansmann, G., & Hoeper, M. M. (2013) · European Respiratory Journal · doi:10.1183/09031936.00065713 · Cited by 29
Self-citationTransition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients
Zopey, R., Susanto, I., Barjaktarević, I., et al. (2013) · Case Reports in Pulmonology · doi:10.1155/2013/561870 · Cited by 29
Chronic thromboembolic pulmonary hypertension: advances from bench to patient management
Pepke‐Żaba, J., Hoeper, M. M., & Humbert, M. J. C. (2012) · European Respiratory Journal · doi:10.1183/09031936.00181212 · Cited by 29
Self-citationForgotten Gold in Diagnosing Pulmonary Hypertension: The Plain Chest Radiograph
Milne, E. N. C. (2012) · Radiographics · doi:10.1148/rg.324125021 · Cited by 27
Echocardiography in tetralogy of Fallot
Dadlani, G. H., John, J. B., & Cohen, M. S. (2008) · Cardiology in the Young · doi:10.1017/s1047951108003260 · Cited by 22
Optimal diuretic therapy for heart failure
Cohn, J. N. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00915-9 · Cited by 22
Lipshultz, S. E., & Wilkinson, J. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs402 · Cited by 22
Taichman, D. B., McGoon, M. D., Harhay, M. O., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.7.586 · Cited by 21
Meng, J., Zhang, L., Wang, Q., et al. (2013) · PubMed · Cited by 16
Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?
Coghlan, G. (2013) · European Respiratory Journal · doi:10.1183/09031936.00025413 · Cited by 15
Self-citationExtensive right pulmonary artery dissection in a young patient with chronic pulmonary hypertension
Russo, V. C., Zompatori, M., & Galiè, N. (2011) · Heart · doi:10.1136/heartjnl-2011-301132 · Cited by 15
Self-citationIssues related to the management and therapy of paediatric pulmonary hypertension
Schulze‐Neick, I., & Beghetti, M. (2010) · European Respiratory Review · doi:10.1183/09059180.00008510 · Cited by 15
Self-citation
Research works printed but not linked: 2
- Galiè, 2014, Anticoagulant therapy does not influence long-term outcomes in patients with pulmonary arterial hypertension (PAH): insights from the randomised controlled SERAPHIN trial of macitentan, Eur Heart J, 35, 10
- Galiè, 2013, New treatment strategies for pulmonary arterial hypertension: hopes or hypes, J Am Coll Cardiol, 62, 1101, 10.1016/j.jacc.2013.06.032 · DOI
Cited by
Sorted by citations
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Self-citationHaemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
Self-citation2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
Self-citation2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958
Self-citationUpdate of EULAR recommendations for the treatment of systemic sclerosis
Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., Distler, O., Clements, P., Cutolo, M., Czirjak, L., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209909 · Cited by 1,104
Self-citation
Metadata
- Authors
- Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., Ghofrani, A., Gomez Sanchez, M. A., Hansmann, G., Klepetko, W., Lancellotti, P., Matucci, M., McDonagh, T., Pierard, L. A., Trindade, P. T., Zompatori, M., Hoeper, M., ESC Scientific Document Group, Aboyans, V., Vaz Carneiro, A., Achenbach, S., Agewall, S., Allanore, Y., Asteggiano, R., Badano, L. P., Barberá, J. A., Bouvaist, H., Bueno, H., Byrne, R. A., Carerj, S., Castro, G., Erol, Ç., Falk, V., Funck-Brentano, C., Gorenflo, M., Granton, J., Iung, B., Kiely, D. G., Kirchhof, P., Kjellstrom, B., Landmesser, U., Lekakis, J., Lionis, C., Lip, G. Y. H., Orfanos, S. E., Park, M. H., Piepoli, M. F., Ponikowski, P., Revel, M.-P., Rigau, D., Rosenkranz, S., Völler, H., Zamorano, J. L., Zamorano, J. L., Aboyans, V., Achenbach, S., Agewall, S., Badimon, L., Barón-Esquivias, G., Baumgartner, H., Bax, J. J., Bueno, H., Carerj, S., Dean, V., Erol, Ç., Fitzsimons, D., Gaemperli, O., Kirchhof, P., Kolh, P., Lancellotti, P., Lip, G. Y., Nihoyannopoulos, P., Piepoli, M. F., Ponikowski, P., Roffi, M., Torbicki, A., Vaz Carneiro, A., Windecker, S., Myftiu, S., Bonderman, D., Firdovsi, I., Lazareva, I., De Pauw, M., Sokolovic, Š., Velchev, V., Cikeš, M., Moutiris, J. A., Jansa, P., Nielsen-Kudsk, J. E., Anton, L., Jääskeläinen, P., Bauer, F., Chukhrukidze, A., Opitz, C., Giannakoulas, G., Karlócai, K., Oddsson, H., Gaine, S., Menachemi, D., Emdin, M., Sooronbaev, T., Rudzitis, T. A., Gumbiene, L., Lebrun, F., Micallef, J., Botnaru, V., Oukerraj, L., Andreassen, A. K., Kurzyna, M., Leite Baptista, M. J. R., Coman, I. M., Moiseeva, O., Stefanovic, B. S., Šimková, I., Wikström, G., Schwerzmann, M., Srbinovska-Kostovska, E., van Dijk, A. P. J., Mahdhaoui, A., Kaymaz, C., Coghlan, G., & Sirenko, Y.
- Affiliations
- University of Bologna (IT)
- Université Paris-Sud (FR)
- ORCID
- Galiè, Nazzareno
- Humbert, Marc
- Lang, Irene
- Simonneau, Gérald
- Beghetti, Maurice
- Hansmann, Georg
- Klepetko, Walter
- Trindade, Pedro T.
- Hoeper, Marius
- Asteggiano, Riccardo
- Badano, Luigi Paolo
- Falk, Volkmar
- Iung, Bernard
- Kiely, David G
- Landmesser, Ulf
- Lionis, Christos
- Park, Myung H
- Revel, Marie-Pierre
- Bax, Jeroen J
- Kolh, Philippe
- Windecker, Stephan
- Giannakoulas, George
- Botnaru, Victor
- Kurzyna, Marcin
- Šimková, Iveta
- Coghlan, Gerry
- Sirenko, Yuriy
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-08-29
- Volume
- 37
- Issue
- 1
- Pages
- 67-119
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2161370807
- Cited by
- 6,931
- References
- 471
- Citations by year
- 2026: 174 · 2025: 297 · 2024: 408 · 2023: 560 · 2022: 778 · 2021: 953 · 2020: 930 · 2019: 794 · 2018: 801 · 2017: 659 · 2016: 461 · 2015: 65
- FWCI
- 524.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Open Repository and Bibliography (University of Liège) (submittedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- IRIS (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Respiratory Society
- European Society of Cardiology
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Congenital Heart Disease Studies
- Keywords
- pulmonary hypertension, diagnosis, treatment, right ventricular function, pulmonary circulation, congenital heart disease, valvular heart disease, heart failure, pharmacotherapy, cardiovascular surgery
- MeSH terms
- Adult, Algorithms, Antihypertensive Agents, Arrhythmias, Cardiac, Child, Combined Modality Therapy, Connective Tissue Diseases, Cross Infection, Drug Interactions, Echocardiography, Electrocardiography, Exercise Test, Exercise Therapy, Female, Genetic Counseling, Genetic Testing, Health Status, Cardiac Catheterization, Heart Defects, Congenital, Hemangioma, Hemoptysis, Humans, Hypertension, Portal, Hypertension, Pulmonary, Patient Compliance, Pregnancy, Pregnancy Complications, Cardiovascular, Referral and Consultation, Respiratory Function Tests, Risk Factors, Social Support, Terminal Care, Thromboembolism, Tomography, X-Ray Computed, Biomarkers, HIV Infections, Lung Transplantation, Treatment Outcome, Elective Surgical Procedures, Ventricular Dysfunction, Right, Risk Assessment, Magnetic Resonance Angiography, Therapies, Investigational, Travel Medicine, Balloon Embolectomy, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
